Cargando…

Molecular Regulatory Mechanism and Toxicology of Neurodegenerative Processes in MPTP/Probenecid-Induced Progressive Parkinson’s Disease Mice Model Revealed by Transcriptome

Parkinson’s disease (PD) is a neurodegenerative disease caused by a variety of unclear complex pathogenic factors. The 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine/probenecid (MPTP/p)-induced progressive PD mice is a well-recognized classic model for studying PD, but the molecular toxicology of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Weiwei, Hao, Wenwen, Meng, Zhuo, Ding, Shiyan, Li, Xiaodi, Zhang, Tao, Huang, Weixiao, Xu, Lian, Zhang, Yu, Yang, Jian, Gu, Xiaosong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843579/ https://www.ncbi.nlm.nih.gov/pubmed/32997292 http://dx.doi.org/10.1007/s12035-020-02128-5

Ejemplares similares

Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models
por: He, Xuan, et al.
Publicado: (2019)

Effects of treadmill exercise on hippocampal neurogenesis in an MPTP /probenecid-induced Parkinson’s disease mouse model
por: Sung, Yun-Hee
Publicado: (2015)

TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson’s disease
por: Shao, Qian-hang, et al.
Publicado: (2019)

A Comprehensive Phenotype of Non-motor Impairments and Distribution of Alpha-Synuclein Deposition in Parkinsonism-Induced Mice by a Combination Injection of MPTP and Probenecid
por: Han, Na-Ra, et al.
Publicado: (2021)

A transcriptomic study of probenecid on injured spinal cords in mice
por: Zhang, Yu-Xin, et al.
Publicado: (2020)

Influences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice
por: Janakiraman, Udaiyappan, et al.
Publicado: (2016)

Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2020)

Retraction: Influences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice
Publicado: (2020)

Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson’s disease
por: Peng, Qinyu, et al.
Publicado: (2022)

Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers
por: Zhang, Yi-fan, et al.
Publicado: (2016)

Effect of Probenecid on Pharmacokinetics and Tolerability of Olmesartan in Healthy Chinese Volunteers()
por: Li, Kun-Yan, et al.
Publicado: (2014)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
por: Murray, Jackelyn, et al.
Publicado: (2022)

Restoration of intestinal function in an MPTP model of Parkinson’s Disease
por: Ellett, L. J., et al.
Publicado: (2016)

Whole Transcriptome Analysis of Substantia Nigra in Mice with MPTP-Induced Parkinsonism Bearing Defective Glucocerebrosidase Activity
por: Usenko, Tatiana, et al.
Publicado: (2023)

Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model
por: Liu, Yingjuan, et al.
Publicado: (2020)

Regulatory toxicology /
Publicado: (2001)

Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy
por: Gutman, Julie, et al.
Publicado: (2012)

MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
por: Li, Dongsheng, et al.
Publicado: (2017)

Metabolic Disturbances in the Striatum and Substantia Nigra in the Onset and Progression of MPTP-Induced Parkinsonism Model
por: Lu, Yi, et al.
Publicado: (2018)

Autotransphntation of the Cervical Sympathetic Ganglion into Monkeys With MPTP-Induced Parkinsonism
por: Itakura, Toru, et al.
Publicado: (1992)

Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2015)

Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection
por: Omar, Noor Azzizah, et al.
Publicado: (2023)

Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease
por: Ma, Chunmei, et al.
Publicado: (2023)

Lycium barbarum polysaccharide improves dopamine metabolism and symptoms in an MPTP-induced model of Parkinson’s disease
por: Song, Jiangbo, et al.
Publicado: (2022)

Anti-Inflammatory and Neuroprotective Effects of Morin in an MPTP-Induced Parkinson’s Disease Model
por: Hong, Dong Geun, et al.
Publicado: (2022)

Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice
por: Shi, Xiaojin, et al.
Publicado: (2016)

Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson’s Disease
por: Guo, Tong-Tong, et al.
Publicado: (2023)

Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells
por: Ebert, Regina, et al.
Publicado: (2014)

Oral probenecid improves sperm motility in men with spinal cord injury
por: Ibrahim, Emad, et al.
Publicado: (2018)

Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro
por: Murray, Jackelyn, et al.
Publicado: (2021)

Oral Probenecid for Nonhospitalized Adults with Symptomatic Mild-to-Moderate COVID-19
por: Martin, David E., et al.
Publicado: (2023)

Crocetin Alleviates Inflammation in MPTP-Induced Parkinson's Disease Models through Improving Mitochondrial Functions
por: Dong, Na, et al.
Publicado: (2020)

Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease
por: Hu, Shanshan, et al.
Publicado: (2020)

The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease
por: Mustafa, S., et al.
Publicado: (2016)

Social behavioral changes in MPTP-treated monkey model of Parkinson's disease
por: Durand, Elodie, et al.
Publicado: (2015)

Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson's disease
por: Bagga, Puneet, et al.
Publicado: (2016)

The Neuroprotective Effects of Cinnamic Aldehyde in an MPTP Mouse Model of Parkinson’s Disease
por: Bae, Woom-Yee, et al.
Publicado: (2018)

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease
por: Huang, Dongping, et al.
Publicado: (2017)

The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease
por: Schwenkgrub, Joanna, et al.
Publicado: (2017)

Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives
por: Wianny, Florence, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pmgqcee05feo3q3up2fa7hl837